Chronological Age Interacts with the Circadian Melatonin Receptor 1B Gene Variation, Determining Fasting Glucose Concentrations in Mediterranean Populations. Additional Analyses on Type-2 Diabetes Risk.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
29 Oct 2020
Historique:
received: 03 09 2020
revised: 21 10 2020
accepted: 24 10 2020
entrez: 3 11 2020
pubmed: 4 11 2020
medline: 15 4 2021
Statut: epublish

Résumé

Gene-age interactions have not been systematically investigated on metabolic phenotypes and this modulation will be key for a better understanding of the temporal regulation in nutrigenomics. Taking into account that aging is typically associated with both impairment of the circadian system and a decrease in melatonin secretion, we focused on the melatonin receptor 1B (MTNR1B)-rs10830963 C>G variant that has been associated with fasting glucose concentrations, gestational diabetes, and type-2 diabetes. Therefore, our main aim was to investigate whether the association between the MTNR1B-rs10830963 polymorphism and fasting glucose is age dependent. Our secondary aims were to analyze the polymorphism association with type-2 diabetes and explore the gene-pregnancies interactions on the later type-2 diabetes risk. Three Mediterranean cohorts (

Identifiants

pubmed: 33138317
pii: nu12113323
doi: 10.3390/nu12113323
pmc: PMC7692445
pii:
doi:

Substances chimiques

Blood Glucose 0
MTNR1B protein, human 0
Receptor, Melatonin, MT2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : CIBER 06/03
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : PI06/1326
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : PI13/00728
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : PI16/00366
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : SAF2016-80532-R
Organisme : the University Jaume I
ID : P1-1B2013-54
Organisme : the University Jaume I
ID : COGRUP/2016/06
Organisme : the Rei Jaume I Award for Medical Research 2018
ID : PRJI2018
Organisme : the Fundació La Marató de TV3
ID : 538/U/2016
Organisme : the Generalitat Valenciana
ID : PROMETEO2017/017
Organisme : the Generalitat Valenciana
ID : APOSTD/2019/136
Organisme : the US Department of Agriculture, Agriculture Research Service
ID : 8050-51000-098-00D
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : PI19/00781

Références

J Hum Genet. 2003;48(10):520-524
pubmed: 14505229
Diabetes. 2009 Nov;58(11):2703-8
pubmed: 19651812
Curr Diab Rep. 2017 Oct 23;17(12):122
pubmed: 29063374
Lancet Diabetes Endocrinol. 2018 May;6(5):416-426
pubmed: 29433995
Nat Genet. 2009 Jan;41(1):82-8
pubmed: 19060908
Arch Physiol Biochem. 2020 Jun 10;:1-22
pubmed: 32520581
J Am Coll Nutr. 2020 Jan;39(1):5-15
pubmed: 31855126
BMC Med Genet. 2010 Apr 14;11:59
pubmed: 20398260
Diabetologia. 2009 Aug;52(8):1537-42
pubmed: 19455304
Soc Sci Med. 1989;29(12):1351-62
pubmed: 2697946
Br J Pharmacol. 2018 Aug;175(16):3190-3199
pubmed: 29318587
Am J Clin Nutr. 2018 Jul 1;108(1):188-200
pubmed: 29901700
Diabetes. 2020 Feb;69(2):259-266
pubmed: 31757795
Am J Hum Genet. 2014 Jul 3;95(1):24-38
pubmed: 24954895
Diabetes. 2011 Jun;60(6):1805-12
pubmed: 21515849
Nutrients. 2018 Oct 18;10(10):
pubmed: 30340375
Hum Exp Toxicol. 2015 Sep;34(9):859-68
pubmed: 26286521
Diabetologia. 2011 Apr;54(4):783-8
pubmed: 21188353
Atherosclerosis. 2014 Jul;235(1):84-93
pubmed: 24819747
Molecules. 2018 Feb 27;23(3):
pubmed: 29495460
Diabet Med. 2014 Mar;31(3):292-301
pubmed: 24341443
Clin Nutr. 2019 Feb;38(1):191-196
pubmed: 29275919
Trends Endocrinol Metab. 2020 Mar;31(3):192-204
pubmed: 31901302
Int J Mol Sci. 2019 Mar 11;20(5):
pubmed: 30862067
Nat Genet. 2009 Jan;41(1):77-81
pubmed: 19060907
Am J Physiol. 1996 Aug;271(2 Pt 1):E246-52
pubmed: 8770017
Ann Hum Genet. 2011 Sep;75(5):589-97
pubmed: 21777205
JAMA. 2020 Aug 25;324(8):735-736
pubmed: 32766768
Diabetes. 2009 Dec;58(12):2939-45
pubmed: 19741166
Diabetes. 2016 Jun;65(6):1490-2
pubmed: 27222395
Eur J Endocrinol. 2013 Jul 29;169(3):291-7
pubmed: 23761423
Cell Mol Life Sci. 2014 Aug;71(16):2997-3025
pubmed: 24554058
Diabetes. 2015 May;64(5):1853-66
pubmed: 25524916
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2284-2290
pubmed: 29590381
Lancet Diabetes Endocrinol. 2020 Sep;8(9):793-800
pubmed: 32822601
Biosci Rep. 2019 Dec 20;39(12):
pubmed: 31808503
Circulation. 2002 Oct 29;106(18):2315-21
pubmed: 12403660
Nat Rev Endocrinol. 2019 Feb;15(2):105-125
pubmed: 30531911
PLoS One. 2015 May 14;10(5):e0126408
pubmed: 25973943
Diabetologia. 2009 May;52(5):830-3
pubmed: 19241057
PLoS One. 2008;3(12):e3962
pubmed: 19088850
Arch Physiol Biochem. 2020 Jun 5;:1-12
pubmed: 32501767
Circulation. 2006 May 2;113(17):2062-70
pubmed: 16636175
Nat Genet. 2009 Jan;41(1):89-94
pubmed: 19060909
Sci Rep. 2016 Oct 26;6:36202
pubmed: 27782183
Diabetes Care. 2020 Sep;43(9):2289-2292
pubmed: 32616615
J Endocr Soc. 2020 Aug 27;4(11):bvaa115
pubmed: 33094207
J Pineal Res. 2008 Jan;44(1):26-40
pubmed: 18078445
Genes Nutr. 2020 Aug 5;15(1):13
pubmed: 32758123
Br J Pharmacol. 2016 Sep;173(18):2702-25
pubmed: 27314810
Sci Rep. 2016 Jul 29;6:30539
pubmed: 27468700
Arch Gynecol Obstet. 2016 Jul;294(1):55-61
pubmed: 26563312
Curr Pharm Des. 2014;20(30):4841-53
pubmed: 24251676
G3 (Bethesda). 2019 Oct 7;9(10):3225-3238
pubmed: 31416806
Endocrinology. 2011 Apr;152(4):1253-63
pubmed: 21303940
PLoS One. 2018 Mar 12;13(3):e0194321
pubmed: 29529059
Nutrients. 2019 Jan 04;11(1):
pubmed: 30621171
BMJ. 2018 Jun 13;361:bmj.k2173
pubmed: 29898881
Diabetologia. 2014 Jul;57(7):1391-9
pubmed: 24728128
Sleep. 2014 Oct 01;37(10):1715-9
pubmed: 25197811
Prog Brain Res. 2010;181:127-51
pubmed: 20478436
Atherosclerosis. 2011 Jul;217(1):139-41
pubmed: 21466885
Cell Metab. 2016 Jun 14;23(6):1067-1077
pubmed: 27185156
Psychoneuroendocrinology. 2006 Jun;31(5):634-41
pubmed: 16584848
PLoS One. 2017 Jan 10;12(1):e0169781
pubmed: 28072873
J Intern Med. 2020 Feb;287(2):189-196
pubmed: 31623012
Nutrients. 2019 Nov 13;11(11):
pubmed: 31766143
PLoS One. 2012;7(11):e50107
pubmed: 23226241
Diabetes. 2009 Jun;58(6):1450-6
pubmed: 19324940
Res Integr Peer Rev. 2016 May 3;1:2
pubmed: 29451543
Life Sci. 2017 Mar 15;173:94-106
pubmed: 28214594
Nutr Hosp. 2019 Mar 7;36(1):60-65
pubmed: 30834760
Eur J Endocrinol. 2011 Feb;164(2):205-12
pubmed: 21059861
J Pineal Res. 2017 Jan;62(1):
pubmed: 27763686
Int J Mol Med. 2018 Feb;41(2):955-961
pubmed: 29207116
Diabetologia. 2020 Nov;63(11):2253-2259
pubmed: 32761356
Experientia. 1993 Aug 15;49(8):654-64
pubmed: 8395408

Auteurs

Jose V Sorlí (JV)

Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Rocío Barragán (R)

Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Medicine, Sleep Center of Excellence, Columbia University Irving Medical Center, New York, NY 10032, USA.

Oscar Coltell (O)

CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Computer Languages and Systems, Universitat Jaume I, 12071 Castellón, Spain.

Olga Portolés (O)

Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Eva C Pascual (EC)

Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.

Carolina Ortega-Azorín (C)

Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

José I González (JI)

Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Ramon Estruch (R)

CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Internal Medicine, Hospital Clinic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Villarroel, 170, 08036 Barcelona, Spain.

Carmen Saiz (C)

Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Alejandro Pérez-Fidalgo (A)

Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
CIBER Cáncer, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Jose M Ordovas (JM)

Nutrition and Genomics Laboratory, JM-USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA.
Precision Nutrition and Obesity Program, IMDEA Alimentación, 28049 Madrid, Spain.

Dolores Corella (D)

Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH